Contact us

  • View funds and model portfolios

    Learn more about our investment products

    How to invest with us

  • Latest insights""Events and webinars""Vanguard outlook 2025""
  • Discover Vanguard 365""

    Learn and earn CPD

    In-depth research for advisers

    Tools and resources for advisers

  • About Vanguard""Contact us""Fraud prevention""

    Corporate reports

    • Contact us

    NAV Price ()
    —
    Number of stocks
    —
    —
    Risk Indicator
    —

    About this fund

    Fund objectives

    • The Fund is a passive fund.
    • The Fund seeks to track the performance of the FTSE All-Share Index (the “Index”).
    • The Index is a free-float market-capitalisation weighted index representing the performance of all eligible companies listed on the London Stock Exchange’s main market, which pass screening for size and liquidity. Free-float means that only shares readily available in the market are included when calculating a company’s weight in a given index and excludes locked-in shares (such as those held by governments). Market-capitalisation is the value of a company’s outstanding shares in the market and shows the size of a company.
    • The Fund attempts to: 1. Track the performance of the Index by investing in a representative sample of Index constituent shares. 2. Remain fully invested and hold small amounts of cash except in extraordinary market, political or similar conditions where the Fund may temporarily depart from this investment policy.

    Fund facts

    Share class inception
    04 Dec 2009
    Minimum initial investment
    £1,000,000.00
    Investment structure
    Authorised Unit Trust (AUT)
    Share Class Assets'
    Total Assets
    Strategy
    Index
    Asset Class
    Equity
    Domicile
    United Kingdom
    Dividend schedule
    —
    Tax status
    —
    Currency
    GBP
    Legal entity
    Vanguard FTSE U.K. All Share Index Unit Trust
    Investment manager

    Vanguard Asset Management, Ltd.
    Europe Equity Index Team

    Benchmark
    FTSE All-Share Index

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Performance

    Risk and Volatility

    As at 31 Oct 2025

    Beta
    R²
    Annualized Tracking Error
    1 year
    3 years
    5 years

    Please note Beta and R-squared data will only display for funds with 3 full years of history.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Portfolio data

    Characteristics
    FundamentalsFundBenchmarkAs at
    Number of stocks 546 540 31 Oct 2025
    Median market capital 51.4 B 51.4 B 31 Oct 2025
    17.5 x 17.5 x 31 Oct 2025
    2.0 x 2.0 x 31 Oct 2025
    9.6% 9.6% 31 Oct 2025
    12.6% 12.6% 31 Oct 2025
    Portfolio turnover rate -7.6% — 31 Oct 2025

    Market allocation

    As at 31 Oct 2025

    CountryRegionFundBenchmarkVariance +/-
    United KingdomEurope 99.66% 100.00% -0.34%
    GuernseyEurope 0.32% 0.00% 0.32%
    JerseyEurope 0.02% 0.00% 0.02%
    BermudaEmerging Markets 0.01% 0.00% 0.01%

    Holdings details

    As at 31 Oct 2025

    Holding name% of market valueSectorRegionMarket valueShares
    AstraZeneca PLC 6.83950% Health Care GB £1,128,950,126.30 9,053,329
    HSBC Holdings PLC 6.76643% Financials GB £1,116,889,998.33 105,030,092
    Shell PLC 6.12645% Energy GB £1,011,253,091.58 35,513,717
    Unilever PLC 4.05232% Consumer Staples GB £668,889,794.82 14,575,938
    Rolls-Royce Holdings PLC 3.62157% Industrials GB £597,788,456.25 51,224,375
    British American Tobacco PLC 2.86108% Consumer Staples GB £472,258,759.68 12,096,792
    GSK PLC 2.63544% Health Care GB £435,014,947.10 24,432,179
    BP PLC 2.57973% Energy GB £425,818,451.26 96,273,672
    RELX PLC 2.25966% Technology GB £372,987,340.38 11,110,734
    Barclays PLC 2.10141% Financials GB £346,865,078.45 85,224,835

    Total allocation percentages shown in the holdings details or the spreadsheet may not equal 100%, due to rounding or omission of cash and/or futures contracts.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Weighted equity exposures exclude any temporary cash investments and equity index derivatives.

    Prices and distribution

    Prices

    NAV Price (GBP)
    £335.46
    Change
    -£0.26-0.08%
    At closure 03 Dec 2025
    NAV 52-week high
    £339.87
    At closure 04 Dec 2025
    NAV 52-week low
    £260.51
    At closure 04 Dec 2025
    NAV 52-week difference
    £79.35
    Change
    +23.35%
    At closure 04 Dec 2025
    Historical Prices

    -

    Inception date

    04 Dec 2009

    Date NAV (GBP)
    03 Dec 2025 £335.4639
    02 Dec 2025 £335.7288
    01 Dec 2025 £335.8160
    28 Nov 2025 £335.0359
    27 Nov 2025 £335.6538
    26 Nov 2025 £335.0480
    25 Nov 2025 £332.0863
    24 Nov 2025 £327.9105
    21 Nov 2025 £329.4892
    20 Nov 2025 £327.6474

    Distribution history

    Distribution frequency

    —

    Historical performance 31 Oct 2025

    2.87%

    All dividends are reinvested for the "Accumulation" shares.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Purchase information

    Currency

    Base currency: GBP

    Fund codes

    • Bloomberg: VUKASSA
    • Citi: HRP3
    • ISIN: GB00B3X7QG63
    • MEX ID: VVFUSI
    • SEDOL: B3X7QG6

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    SEDOL and SEDOL Masterfile® are registered trademarks of the London Stock Exchange Group PLC. SEDOL data was extracted from the London Stock Exchange SEDOL Masterfile®.